论文部分内容阅读
缓释硝苯啶抑制Ca~(2+)内流,为有效治疗心血管病的药物,对于治疗不同形式的心绞痛、轻中度高血压和雷诺氏现象均有效。该药用量每日一次,疗效确切,不良反应小,其特点为不产生反射性心动过速,耐受性好。硝苯啶胃肠治疗系统制剂和缓释硝苯啶/阿替洛尔固定混合胶囊,治疗高血压效果好,前者还有效地用于治疗稳定型心绞痛。缓释硝苯啶治疗高血压、心绞痛的疗效及耐受性优于普通硝苯啶制剂。
Sustained release of nifedipine inhibits Ca ~ (2+) influx, which is an effective treatment for cardiovascular diseases and is effective in treating various forms of angina, mild to moderate hypertension and Raynaud’s phenomenon. The drug dosage once a day, the exact effect, adverse reactions, which is characterized by no reflex tachycardia, well tolerated. Nifedipine gastrointestinal treatment system formulations and sustained-release nifedipine / atenolol fixed mixed capsules, effective in treating hypertension, the former is also effective for the treatment of stable angina. Sustained release of nifedipine for the treatment of hypertension, angina pectoris efficacy and tolerance is superior to ordinary nifedipine formulations.